Abstract:Clostridioides difficile, a Gram-positive anaerobic bacterium, is the leading cause of hospital-acquired antibiotic-associated diarrhea worldwide. The severity of C. difficile infection (CDI) varies, ranging from mild diarrhea to life-threatening conditions such as pseudomembranous colitis and toxic megacolon. Central to the pathogenesis of the infection are toxins produced by C. difficile, with toxin A (TcdA) and toxin B (TcdB) as the main virulence factors. Additionally, some strains produce a third toxin known as C. difficile transferase (CDT). Toxins damage the colonic epithelium, initiating a cascade of cellular events that lead to inflammation, fluid secretion, and further tissue damage within the colon. Mechanistically, the toxins bind to cell surface receptors, internalize, and then inactivate GTPase proteins, disrupting the organization of the cytoskeleton and affecting various Rho-dependent cellular processes. This results in a loss of epithelial barrier functions and the induction of cell death. The third toxin, CDT, however, functions as a binary actin-ADP-ribosylating toxin, causing actin depolymerization and inducing the formation of microtubule-based protrusions. In this review, we summarize our current understanding of the interaction between C. difficile toxins and host cells, elucidating the functional consequences of their actions. Furthermore, we will outline how this knowledge forms the basis for developing innovative, toxin-based strategies for treating and preventing CDI.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is about **how Clostridioides difficile toxins interact with host cells and their roles in the pathogenesis of the disease**. Specifically, the paper focuses on toxin A (TcdA) and toxin B (TcdB), the main virulence factors produced by Clostridioides difficile, and a third toxin, Clostridioides difficile transferase (CDT), produced by some strains. These toxins bind to host cell surface receptors, internalize into the cell interior, and disrupt cytoskeletal organization by glycosylating small GTPases (such as Rho family proteins), affecting various Rho - dependent cellular processes, and ultimately leading to loss of epithelial barrier function and cell death.
### Main problems:
1. **Interaction between toxins and host cells**:
- Describes how toxin A and toxin B bind to host cell surface receptors, internalize into the cell, and disrupt cytoskeletal organization by glycosylating small GTPases (such as RhoA, RhoB, RhoC, Rac1, Rac2, and Cdc42).
- Discusses how these toxins affect cell signaling, cytoskeletal organization, the integrity of tight junctions between cells, apoptosis, and acute inflammatory responses.
2. **Structure and function of toxins**:
- Describes in detail the four - domain structure of toxin A and toxin B, including the glycosyltransferase domain (GTD), the intrinsic cysteine protease domain, the delivery and receptor - binding domain (DRBD), and the C - terminal repeat oligopeptide (CROPS) domain.
- Explains the specific roles of these domains in toxin activity, such as the glycosylation function of GTD, the receptor - binding and internalization functions of DRBD, etc.
3. **Regulatory mechanisms of toxins**:
- Describes the location of toxin genes in the Clostridioides difficile genome, especially the tcdA and tcdB genes located in the pathogenicity locus (PaLoc).
- Discusses the roles of regulatory proteins such as TcdR, TcdC, and TcdE in toxin expression and secretion.
4. **Roles of toxins in the pathogenesis of the disease**:
- Analyzes the specific mechanisms by which toxin A and toxin B cause intestinal inflammation, fluid secretion, and tissue damage.
- Discusses the key role of toxin B in human infections, especially in strains lacking toxin A (A−B+ strains), where toxin B can still cause severe diarrhea and pseudomembranous colitis.
5. **Role of inflammatory responses in the outcome of CDI**:
- Describes how the inflammatory responses caused by toxins recruit immune cells (such as dendritic cells and macrophages) and release multiple inflammatory mediators (such as IFN - γ, TNF - α, IL - 1β, IL - 6, IL - 8, and leukotrienes).
- Discusses that while these inflammatory responses protect the host from infection, they may also lead to excessive inflammation and tissue damage, thereby increasing the severity of the disease.
### Conclusion:
The paper summarizes the current understanding of the interaction between Clostridioides difficile toxins and host cells and explores how this knowledge can provide a basis for developing innovative, toxin - based treatment and prevention strategies for Clostridioides difficile infection (CDI). By gaining in - depth understanding of the mechanisms of action of these toxins, researchers can design more effective treatment methods to alleviate the symptoms of CDI and reduce its recurrence rate.